I wonder how Novartis is dealing with Mesoblast now? Who has the upper hand?
NVS - sign here and give your IP away for cheap - you are running out of money anyway
SI - well look at this we have SurgCentre investment
NVS - we are going to hold this up until you get some directions from the FDA
SI - ok, but it will cost you more later - we are going to move on with our next indication CLBP and then the other indications. Do you think there are other pharmas who may be interested in CHF? Dr Perin is almost ready to publish his journal - hmmmm
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-54
-
- There are more pages in this discussion • 287 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $4.638M | 5.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 152669 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 51069 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |